EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Open-Label, Pilot Study of the Safety and Clinical Effects of Rituximab in Patients with Rheumatoid Arthritis-Associated Interstitial Pneumonia

Eric L. Matteson, Tim Bongartz, Jay H. Ryu, Cynthia S. Crowson, Thomas E. Hartman, Paul F. Dellaripa

Open Journal of Rheumatology and Autoimmune Diseases · 2012

DOI: 10.4236/ojra.2012.23011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Journal of Rheumatology and Autoimmune Diseases, 2012. Verfasst von Eric L. Matteson und 5 weiteren Autor:innen. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Matteson, E. L., Bongartz, T., Ryu, J. H., Crowson, C. S., Hartman, T. E., & Dellaripa, P. F. (2012). Open-Label, Pilot Study of the Safety and Clinical Effects of Rituximab in Patients with Rheumatoid Arthritis-Associated Interstitial Pneumonia. Open Journal of Rheumatology and Autoimmune Diseases. https://doi.org/10.4236/ojra.2012.23011

Vancouver

Matteson EL, Bongartz T, Ryu JH, Crowson CS, Hartman TE, Dellaripa PF. Open-Label, Pilot Study of the Safety and Clinical Effects of Rituximab in Patients with Rheumatoid Arthritis-Associated Interstitial Pneumonia. Open Journal of Rheumatology and Autoimmune Diseases. 2012. doi:10.4236/ojra.2012.23011

BibTeX
@article{Matteson2012,
  author = {Matteson, Eric L. and Bongartz, Tim and Ryu, Jay H. and Crowson, Cynthia S. and Hartman, Thomas E. and Dellaripa, Paul F.},
  title = {Open-Label, Pilot Study of the Safety and Clinical Effects of Rituximab in Patients with Rheumatoid Arthritis-Associated Interstitial Pneumonia},
  journal = {Open Journal of Rheumatology and Autoimmune Diseases},
  year = {2012},
  doi = {10.4236/ojra.2012.23011}
}
Kostenlos starten →